Welcome to LookChem.com Sign In|Join Free

Hubei Vanz Pharm Co.,Ltd

Diamond Supplier Enterprise Certification

Diamond
Supplier
6th
years
Home>>Products>>99% Anti-Hair Loss Way316606 Powder cas 915759-45-4

Product Certification&
Enterprise Certification

More Detail

Hubei Vanz Pharm Co.,Ltd

Country: China (Mainland)

Business Type:Trading Company

Ms.Chelsea gao

Tel: 86-27-84492310

Ms.Bella Li

Tel: 008618986076206

Ms.Chelsea Gao

Tel: +86 27 84492310

Ms.Wendy

Tel: WhatsApp +8615927784577

Ms.Mirriam

Tel: +8618071739296

Mobile: +8615207100586

Tel: 86-27-84492310

Fax: 86-27-84402310

URL: http://www.vanzpharm.com/en/index.html

Province/state: Hubei

City: JIAYU

Street: FANHU INDUSTRY PARK

MaxCard:


    x
  • Ms.Bella Li
  • Ms.Chelsea Gao
Contact Suppliers

99% Anti-Hair Loss Way316606 Powder cas 915759-45-4

CAS NO.915759-45-4

  • Min.Order: 1 Gram
  • Payment Terms: L/C,T/T,
Contact Supplier

Product Details

Keywords

  • Way316606
  • Way316606 powder
  • 99% Way316606

Quick Details

  • ProName: 99% Anti-Hair Loss Way316606 Powder ca...
  • CasNo: 915759-45-4
  • Molecular Formula: C18H19F3N2O4S2
  • Appearance: white
  • Application: anti hair loss
  • DeliveryTime: 7-10 days
  • PackAge: drum
  • Port: Shanghai/Wuhan
  • ProductionCapacity: 1000 Kilogram/Day
  • Purity: 99
  • Storage: room
  • LimitNum: 1 Gram

Superiority

 

MOQ: 1g
Form: Powder
Colour: White
Test: HPLC
Function: anti hair loss
Grade: Pharm

 

Details

99% Anti-Hair Loss Way316606 Powder cas 915759-45-4 

product Name WAY 316606 

CAS 915759-45-4 

Molecular Formula C18H19F3N2O4S2 

Molecular Weight 448.479

 Storage Room temperature

 Appearance White powder

 What is WAY-316606
WAY-316606 is used in the treatment of osteoporosis - a condition that causes fragile bones and increases susceptibility to fractures . It's a SFRP1 inhibitor, which means it prevents the protein SFRP1 from being produced and activated  
 

How Does It Work
The protein SFRP1 works as a modulator of the Wnt signaling pathways. These pathways - and more specifically the 'canonical'
pathway - lead to the regulation of gene transcription, which is crucial when determining what role genes will play.pathway has been identified as playing a part in the development of osteoporosis . This occurs as the pathway encourages the development of more bone-resorbing cells (osteoclasts) than bone-forming cells (osteoblasts). It works, then, by triggering the Wnt signaling pathway. This helps the two different cell types to be better differentiated,leading to less bone degradation and further bone growth.